Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
8.18
-0.15 (-1.80%)
At close: Dec 5, 2025, 4:00 PM EST
8.30
+0.12 (1.47%)
After-hours: Dec 5, 2025, 6:56 PM EST
Vor Biopharma Stock Forecast
VOR's stock price has decreased by -54.27% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Vor Biopharma stock ranges from a low of $8.00 to a high of $160. The average analyst price target of $70.43 forecasts a 761.00% increase in the stock price over the next year.
Price Target: $70.43 (+761.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Vor Biopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Initiates $9 | Hold | Initiates | $9 | +10.02% | Nov 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $55 → $32 | Strong Buy | Maintains | $55 → $32 | +291.20% | Nov 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $52 | Strong Buy | Maintains | $3 → $52 | +535.70% | Oct 29, 2025 |
| Baird | Baird | Hold → Buy Upgrades $20 → $64 | Hold → Buy | Upgrades | $20 → $64 | +682.40% | Oct 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +633.50% | Aug 14, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-19.47
from -34.03
EPS Next Year
-8.97
from -19.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -14.07 | -4.16 | ||||
| Avg | -19.47 | -8.97 | ||||
| Low | -24.65 | -11.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.